Stocktoria
agilon health, inc. AGL
agilon health, inc. (AGL) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $5.9B at a -6.6% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.016 |
| Retained earnings / assets | -1.556 |
| EBIT / assets | -0.364 |
| Equity / liabilities | 0.111 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| AGL | agilon health, inc. | 2/9 | -7.3 | — | -2.1% |
| PGNY | Progyny, Inc. | 5/9 | 7.14 | 38.2 | +10.4% |
| SHC | Sotera Health Co | 6/9 | — | 63.6 | +5.7% |
| VMD | VIEMED HEALTHCARE, INC. | 5/9 | 5.41 | 26.5 | +20.5% |
| CCEL | CRYO CELL INTERNATIONAL INC | 5/9 | -3.07 | — | -1.3% |
| NIVF | NewGenIvf Group Ltd | 3/9 | 3.84 | 0.6 | — |
| MGRX | MANGOCEUTICALS, INC. | 2/9 | 2.42 | — | — |
About agilon health, inc.
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
FAQ
Is AGL financially healthy?
agilon health, inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does AGL pay a dividend?
No, agilon health, inc. does not currently pay a dividend.
How profitable is AGL?
In FY2025, agilon health, inc. had a net margin of -6.6% and a return on equity of -308.8%.
What is the analyst price target for AGL?
The average Wall-Street price target for agilon health, inc. is $60.36, about 30.0% below the recent price, from 14 analysts (consensus: hold).
Is AGL a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on agilon health, inc.: a Piotroski F-score of 2/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.